Salugan, Nina H.
HRN: 26-48-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/17/2026
07/23/2026
IV INFUSION X 1 HR
800mg
OD
Decubitus Ulcer
Checking Final Appropriateness
Indication: Culture-directed Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes